Calamos Wealth Management LLC grew its holdings in shares of Morgan Stanley (NYSE:MS - Free Report) by 18.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 96,734 shares of the financial services provider's stock after purchasing an additional 14,933 shares during the period. Calamos Wealth Management LLC's holdings in Morgan Stanley were worth $12,161,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds also recently made changes to their positions in MS. Wilmington Savings Fund Society FSB grew its holdings in shares of Morgan Stanley by 474.3% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 21,134 shares of the financial services provider's stock valued at $2,203,000 after acquiring an additional 17,454 shares in the last quarter. Principal Financial Group Inc. increased its stake in Morgan Stanley by 0.8% during the third quarter. Principal Financial Group Inc. now owns 4,711,805 shares of the financial services provider's stock valued at $491,159,000 after acquiring an additional 36,120 shares during the period. Matrix Trust Co acquired a new position in Morgan Stanley in the 4th quarter valued at approximately $2,040,000. Johnson & White Wealth Management LLC bought a new stake in shares of Morgan Stanley in the 4th quarter worth approximately $597,000. Finally, Natixis Advisors LLC increased its position in shares of Morgan Stanley by 1.4% during the third quarter. Natixis Advisors LLC now owns 1,152,937 shares of the financial services provider's stock valued at $120,182,000 after purchasing an additional 16,350 shares during the period. Institutional investors and hedge funds own 84.19% of the company's stock.
MS stock opened at $137.26 on Tuesday. The stock has a market cap of $221.13 billion, a price-to-earnings ratio of 17.29, a PEG ratio of 1.22 and a beta of 1.36. Morgan Stanley has a fifty-two week low of $83.09 and a fifty-two week high of $141.48. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 3.14. The business has a 50 day moving average price of $129.97 and a 200 day moving average price of $116.20.
Morgan Stanley (NYSE:MS - Get Free Report) last announced its quarterly earnings data on Thursday, January 16th. The financial services provider reported $2.22 earnings per share for the quarter, beating analysts' consensus estimates of $1.54 by $0.68. The company had revenue of $16.23 billion for the quarter, compared to analyst estimates of $15.03 billion. Morgan Stanley had a return on equity of 14.39% and a net margin of 12.48%. The firm's revenue for the quarter was up 25.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.13 EPS. Equities research analysts anticipate that Morgan Stanley will post 8.52 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Friday, January 31st will be paid a $0.925 dividend. This represents a $3.70 dividend on an annualized basis and a dividend yield of 2.70%. The ex-dividend date of this dividend is Friday, January 31st. Morgan Stanley's dividend payout ratio is presently 46.60%.
In related news, insider Eric F. Grossman sold 13,097 shares of the business's stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $136.20, for a total transaction of $1,783,811.40. Following the sale, the insider now owns 197,444 shares of the company's stock, valued at $26,891,872.80. The trade was a 6.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Raja Akram sold 17,500 shares of the firm's stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $136.01, for a total value of $2,380,175.00. Following the sale, the chief financial officer now directly owns 81,440 shares of the company's stock, valued at approximately $11,076,654.40. This represents a 17.69 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.24% of the company's stock.
Several research analysts have recently commented on the company. JPMorgan Chase & Co. boosted their target price on Morgan Stanley from $104.00 to $108.00 and gave the stock a "neutral" rating in a report on Monday, January 13th. Royal Bank of Canada increased their target price on Morgan Stanley from $108.00 to $122.00 and gave the stock a "sector perform" rating in a research note on Thursday, October 17th. Barclays upped their price target on Morgan Stanley from $155.00 to $156.00 and gave the stock an "overweight" rating in a research report on Friday, January 17th. Hsbc Global Res downgraded Morgan Stanley from a "strong-buy" rating to a "hold" rating in a report on Tuesday, November 26th. Finally, UBS Group lifted their price objective on shares of Morgan Stanley from $130.00 to $140.00 and gave the stock a "neutral" rating in a research report on Tuesday, January 21st. Eleven research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Morgan Stanley presently has a consensus rating of "Hold" and a consensus price target of $131.27.
View Our Latest Stock Report on Morgan Stanley
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Morgan Stanley, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Morgan Stanley wasn't on the list.
While Morgan Stanley currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.